Provided by Tiger Trade Technology Pte. Ltd.

WisdomTree BioRevolution Fund

22.14
+0.02900.13%
Post-market: 22.300.1610+0.73%16:10 EDT
Volume:326
Turnover:7K
Market Cap:3.54M
PE:- -
High:22.30
Open:22.30
Low:22.14
Close:22.11
52wk High:24.20
52wk Low:14.40
Shares:160.00K
Float Shares:160.00K
Volume Ratio:0.03
T/O Rate:0.20%
Dividend:0.77
Dividend Rate:3.48%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Trading DAY-Oil, Yields Slide

Reuters
·
Aug 26

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Aug 26

Eli Lilly & Co. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Aug 26

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Aug 26

Eli Lilly Stock (LLY) Rattled as Companies Decline to Cover Weight-Loss Drug Costs

TIPRANKS
·
Aug 26

Moderna Shares Rise After Wolfe Research Upgrade

MT Newswires Live
·
Aug 26

More US Employers to Drop Weight-Loss Drugs in 2027, as Healthcare Costs Increase

Reuters
·
Aug 26

Moderna Stock Gains as Melanoma Vaccine Results De-Risk Approach

Dow Jones
·
Aug 26

Lilly’s LY4395089 Interaction Study Marks Quiet but Important Early-Stage Progress

TIPRANKS
·
Aug 26

Moderna rises 13.0%

TIPRANKS
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

Moderately bullish activity in Moderna with shares up 11.44%

TIPRANKS
·
Aug 25

Moderna Raised to Peer Perform from Underperform by Wolfe Research

Dow Jones
·
Aug 25

What Happens if Moderna's Cancer Vaccine Works

Dow Jones
·
Aug 25

FDA Greenlights Roche and Eli Lilly's Blood-Based Alzheimer's Test, Setting a Single Threshold to Rule Both In and Out Amyloid Pathology

Deep News
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Moderna on Track for Best Month on Record

Dow Jones
·
Aug 25

Early notable gainers among liquid option names on August 25th

TIPRANKS
·
Aug 25

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS
·
Aug 25

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

TIPRANKS
·
Aug 25